Navigation Links
Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors
Date:10/30/2007

SAN MATEO, Calif., Oct. 30 /PRNewswire/ -- Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing anti-inflammatory drugs for chronic and acute diseases, today announced that Donald J. Santel has been appointed to Anthera's Board of Directors.

"Don's experience in transforming early biotech startups into commercial stage organizations will be of benefit as we expand our pipeline and move A-002 into large scale Phase III clinical trials," said Paul F. Truex, President and Chief Executive Officer of Anthera Pharmaceuticals, Inc. "His strategic and operational insights related to the challenges facing development stage companies will be invaluable as Anthera embarks on the next phase of growth."

"We're pleased to have an individual of Don's caliber join our Board of Directors," said Lowell E. Sears Chairman of Anthera's Board of Directors. "We look forward to his contributions that will further shape strategic direction and drive future growth."

Donald J. Santel has 25 years experience in the biotechnology/biopharmaceutical and medical device industries. Most recently, he was Co-Founder and Chief Executive Officer at CoTherix, Inc., where he launched Ventavis(R) Inhalation Solution and led the sale of the company to Actelion Pharmaceuticals, Ltd. in January 2007. Prior to CoTherix, he served as President and Chief Operating Officer of Reflow, and sold the company to Fox Hollow (now EV3) and served as Vice President of Marketing and International Sales at Cardiac Pathways Corporation, a medical device company later acquired by Boston Scientific. Mr. Santel began his career at Medtronic, Inc. Mr. Santel also serves on the board of Hyperion Therapeutics. He has a BSE from Purdue University and an MS in from the University of Minnesota.

About Anthera Pharmaceuticals

Anthera Pharmaceuticals is a privately-held pharmaceutical development company committed to world-class development and commercialization of pr
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. McDonalds: French Fries, Transparent to more Trans -Fats
2. French fries by McDonalds fries in another controversy
3. Hospital Withdraws McDonalds Reward Scheme
4. Fat Content In McDonald’s & KFCs Foods Varies From Country To Countr
5. McDonald Sets Aside Promises of Healthy Menu
6. Bird flu no threat to McDonalds chicken: Advertisement strategy
7. Hepatitis Scare at McDonald’
8. McDonalds to Start Coffee Chain in Japan
9. Study casts doubt on keyboard ills
10. Who Board To Discuss Asian Tsunami Related Health Issues
11. Abdominal Crunches Not The Best Option For Wash Board Abs.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...ar herpes simplex virus is a common eye disease af...have the disease, and about 50,000 new cases are i...e HSV-type 1 virus. Most people who get the infe...currence rate is about 20 percent within two years...
...xic Respiratory Failure ( HRF ) develops when newb...body. //It can happen to full-term and near-term i...to predict which infants will develop HRF, so ther.... The standard treatment is a surgical procedure t...
...archers from the University of Florida College of ...two different treatments for hypertension in older... more than one medication to control their blood p...at multidrug strategies rather than individual dru...
...ntists believe they’ve found a simple new test to ...ble stage.// In a report published in this week’s...ed on an analysis of a person’s urine. Kidney canc...percent of all cancers. About 32,000 cases were id...
Other Medicine News:
(Date:9/5/2008)...SAN FRANCISCO, Calif., Sept. 5 /PRNewswire-FirstCa...sed on small molecule LFA-1 inhibitors,to treat in...Inc. (Nasdaq:,SNSS) today announced SARcode,s init...cule LFA-1 product candidate for T-cell mediated o...to a license agreement providing,SARcode with an e...
(Date:9/4/2008)... awarded orphan designation for the treatment of A...ia, PRINCETON, N.J., Sept. 4 /- Cela...Food & Drug Administration (FDA) has granted orpha...icin) Liposome Injection,for the treatment of Acut...reparing to conduct two randomized Phase 2,studies...
(Date:9/4/2008)...ce Bulletin for Obstetrician-Gynecologists States ...hange-Minimally Invasive Interventional,Radiology ... Uterine,Fibroids, FAIRFAX, Va., Sept. 4 /PRNewsw...adiology, a national organization of nearly 4,500 ...s dedicated to improving health,care through minim...
(Date:9/4/2008)... Updated Survival Data for Ipilimumab to be Prese...all/ -- Medarex, Inc.,(Nasdaq: MEDX ) announced t...an investigational anti-CTLA-4 antibody, in melano...s at the 33rd Congress of the European Society,for...6, 2008 in Stockholm.,Many of the following abstra...
Breaking Medicine Technology:SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 3Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 3Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3AcroMetrix Releases New OptiQuant 28R 29 HIV 1 Quantification Panel 598 1AcroMetrix Releases New OptiQuant 28R 29 HIV 1 Quantification Panel 598 2Dynavax Begins TOLAMBA 28TM 29 Environmental Exposure Chamber Study 596 1Dynavax Begins TOLAMBA 28TM 29 Environmental Exposure Chamber Study 596 2Dynavax Begins TOLAMBA 28TM 29 Environmental Exposure Chamber Study 596 3Weight gain related to postmenopausal breast cancer risk 4302 1Weight gain related to postmenopausal breast cancer risk 4302 2Whole Grains Do a Heart Good 4300 1Whole Grains Do a Heart Good 4300 2Whole Grains Do a Heart Good 4300 3
...ons Unite to Help Educate on Good,Diabetes Managem...alth Problems, SEATTLE, April 10, 2007 /PRNewswire...valence and cost of type 2 diabetes,complications ...57.9 percent) with type 2 diabetes have at least o...ssociated with the disease, and,that these health ...
...ewswire-FirstCall/ -- ImClone,Systems Incorporated...that a Phase III study of ERBITUX(R) (Cetuximab) p...locally advanced,unresectable or metastatic pancre...mproving overall survival. , Conducted by the Sout...rk sponsored by the National Cancer Institute, the...
Other Medicine Technology:First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 2First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 3First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 4First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 5First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 6First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 7Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 2Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 3Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 4Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 5Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 6Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 7Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 8Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 9
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
Medicine Products: